Treatment Guidelines from The Medical Letter
Drugs for Allergic Disorders
The full article is available to subscribers Subscriber Login   

The use of drugs to prevent and control symptoms of allergic disorders can be optimized when patients avoid exposure to specific allergens and/or environmental conditions that trigger or worsen their symptoms.


Allergic rhinitis can be seasonal/intermittent or perennial/ persistent. It is often associated with allergic conjunctivitis, rhinosinusitis and asthma.1,2

H1-ANTIHISTAMINES — Oral – Orally administered second-generation H1-antihistamines are the preferred first-line therapy for relief of the itching, sneezing and rhinorrhea that characterize mild to moderate allergic rhinitis. They are less effective for nasal congestion. Second-generation H1-antihistamines penetrate poorly into the central nervous system and are significantly less likely than the first-generation agents to impair CNS function and ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: Drugs for Allergic Disorders
Article code: 129a
 Electronic, downloadable article - $25